| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CDTX (CDTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CDTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.65M | $465.23 | - | |
| CFO | 43.1K | $9.55M | - | |
| Other | 8.3K | $1.85M | - | |
| Dir | 0 | - | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2023 | Shah Preetam | CFO &Cbo | Sell | 6,648 | $1.53 | $10,171.44 | -4.3% | -28.9% | -60.5% | |
| Mar 13, 2023 | Sandison Taylor45 | Chief Medical Officer | Sell | 7,203 | $1.53 | $11,020.59 | -2.4% | -28.9% | -60.5% | |
| Jan 12, 2023 | Tari Leslie60 | Chief Scientific Officer | Sell | 11,814 | $1.20 | $14,176.80 | -88.8% | -9.2% | -36.2% | |
| Sep 19, 2022 | Shah Preetam | CFO &Cbo | Sale+OE | 15,642 | $0.77 | $12,034.95 | -9.4% | -36.6% | +38.2% | |
| Sep 12, 2022 | Sandison Taylor45 | Chief Medical Officer | Sell | 18,478 | $0.68 | $12,655.58 | -6.0% | -22.7% | +44.4% | |
| Sep 12, 2022 | Tari Leslie60 | Chief Scientific Officer | Sell | 18,159 | $0.68 | $12,437.10 | -8.6% | -22.7% | +44.4% | |
| Sep 12, 2022 | Daruwala Paul58 | Chief Operating Officer | Sell | 16,199 | $0.68 | $11,094.70 | -6.8% | -22.7% | +44.4% | |
| Mar 21, 2022 | Johnson Brady | Vice President, Finance | Sell | 654 | $0.81 | $529.74 | -1.3% | -33.5% | +149.8% | |
| Mar 11, 2022 | Johnson Brady | Vice President, Finance | Sell | 945 | $0.71 | $670.95 | -1.9% | -18.1% | +116.5% | |
| Jan 5, 2022 | Johnson Brady | Vice President, Finance | Sale+OE | 416 | $1.25 | $520.00 | -0.8% | -22.2% | -29.1% |